Cite

HARVARD Citation

    Hassaniazad, M. et al. (2021). A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID‐19 patients. Phytotherapy research. pp. 6417-6427. [Online]. 
  
Back to record